In vitro search for synergy and antagonism: evaluation of docetaxel combinations in breast cancer cell lines.
- 1 July 2002
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 74 (1), 41-46
- https://doi.org/10.1023/a:1016070230538
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- In vitro effects of dexrazoxane (Zinecard) and classical acute leukemia therapy: time to consider expanded clinical trials?Leukemia, 2001
- Dexrazoxane (ICRF-187)General Pharmacology: The Vascular System, 1999
- Taxanes in the Treatment of Breast Cancer: A Prodigy Comes of AgeCancer Investigation, 1999
- Docetaxel in combination with doxorubicin or vinorelbineEuropean Journal Of Cancer, 1997
- Three-drug combination of MKC-442, lamivudine and zidovudine in vitroAIDS, 1997
- In vitro synergy of paclitaxel (Taxol) and vinorelbine (navelbine) against human melanoma cell linesEuropean Journal Of Cancer, 1997
- Synergistic Interaction Between Dehydroepiandrosterone and Prednisolone in the Inhibition of Rat Lymphocyte ProliferationImmunopharmacology and Immunotoxicology, 1996
- Current status of Taxotere® (docetaxel) as a new treatment in breast cancerBreast Cancer Research and Treatment, 1995
- Computerized Quantitation of Synergism and Antagonism of Taxol, Topotecan, and Cisplatin Against Human Teratocarcinoma Cell Growth: a Rational Approach to Clinical Protocol DesignJNCI Journal of the National Cancer Institute, 1994
- The pharmacology and toxicology of disulfiram and its metabolitesActa Psychiatrica Scandinavica, 1992